PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1067

  1. 18 Posts.
    lightbulb Created with Sketch. 6
    Very interesting, these agents are normally used in the treatment of depression. I have also seen it prescribed by neurologists for management of neuropathic (nerve related) pain. I wonder if this is exploring a different angle or looking at neuropathi pain again.

    my views as always

    shifty
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.